oral glp 1 vs injectable 3 Takeaways from the Landmark GLP-1 'Switch' Trial for Obesity Care Oral GLP-1 Pills vs Injections:

Unlike FDA-approved medications (e.g., Wegovy, Ozempic, Zepbound), compounded alternatives lack agency review for safety, quality, and efficacy

Monotherapy showed higher AE rates

In our newly released white paper, From Managing Illness to Building Health, we outline why fragmented, condition-specific approaches are no longer aligned with clinical science or financial outcomes and what a more integrated, prevention-focused model looks like in practice

Plant Collagen Fragments: Biomimetic to human collagen fragments, plant collagen fragments visibly lift skin, improving sagging and deflated skin

Given the potential for increased INR variability, clinicians may consider increasing INR monitoring frequency following GLP-1 RA initiation.

G49, a dual glucagon/glucagon-like peptide-1 receptor agonist, triggers an inter-organ crosstalk between adipose tissue, pancreas and liver, leading to brown fat activation with the final outcomes of increased energy expenditure and body weight loss.